Editas Medicine, Inc. - Common Stock, $0.0001 par value per share (EDIT)

Historical Holders from Q1 2016 to Q1 2025

Symbol
EDIT on Nasdaq
CUSIP
28106W103
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
82.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
51M
Holdings value
$64.8M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
196
Number of buys
83
Number of sells
-115
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Editas Medicine, Inc. - Common Stock, $0.0001 par value per share (EDIT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.9% $7.59M 6.54M BlackRock, Inc. Mar 31, 2025

Institutional Holders of Editas Medicine, Inc. - Common Stock, $0.0001 par value per share (EDIT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 876K $1.02M +$88.2K $1.16 25
2024 Q4 51M $64.8M -$27M $1.27 196
2024 Q3 55M $188M -$7.64M $3.41 222
2024 Q2 56.4M $263M -$55.7M $4.67 230
2024 Q1 67.9M $504M +$59.2M $7.42 222
2023 Q4 58.5M $593M -$37.4M $10.13 218
2023 Q3 61.3M $478M -$13.7M $7.80 215
2023 Q2 62.2M $512M +$81.1M $8.23 228
2023 Q1 52.7M $382M -$12.5M $7.25 226
2022 Q4 53.5M $475M +$43.2M $8.87 238
2022 Q3 48.2M $590M +$9.04M $12.24 236
2022 Q2 47.4M $560M +$5.76M $11.83 228
2022 Q1 44M $837M -$138M $19.02 230
2021 Q4 50.9M $1.35B -$59.1M $26.55 285
2021 Q3 51.7M $2.12B -$9.82M $41.08 305
2021 Q2 52.1M $2.96B -$26.5M $56.64 308
2021 Q1 51.5M $2.16B +$4.78M $42.00 292
2020 Q4 52.9M $3.71B -$146M $70.11 298
2020 Q3 55.1M $1.54B +$17.2M $28.06 230
2020 Q2 54M $1.6B +$264M $29.58 221
2020 Q1 45.3M $898M -$11.8M $19.83 180
2019 Q4 45.7M $1.35B +$25.7M $29.61 215
2019 Q3 44M $1B +$119M $22.74 175
2019 Q2 38.7M $958M +$75.4M $24.74 182
2019 Q1 37.4M $915M +$72.9M $24.45 191
2018 Q4 34.4M $782M +$24.5M $22.75 183
2018 Q3 32.7M $1.04B +$36M $31.82 188
2018 Q2 31.9M $1.14B +$39.8M $35.83 206
2018 Q1 30.9M $1.03B +$25M $33.15 189
2017 Q4 30.2M $929M +$79.2M $30.73 141
2017 Q3 27.2M $652M +$40.5M $24.01 112
2017 Q2 29.2M $490M +$21.1M $16.78 107
2017 Q1 27.5M $614M +$121M $22.32 99
2016 Q4 23.5M $381M +$22.3M $16.23 83
2016 Q3 22.2M $299M +$9.01M $13.48 70
2016 Q2 17.6M $429M -$15.1M $24.40 64
2016 Q1 18.2M $625M +$464M $34.54 48